SUN PHARMACEUTICAL IND L vs VIJAYA DIAGNOSTIC CEN LTD
A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs VIJAYA on 8 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- − ["Stock is trading at 14.9 times its book value", "Working capital days have increased from -3.87 days to 65.1 days"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.